# A Long-term Follow-up Study of Patients Who Received VOR33

> **NCT05309733** · — · TERMINATED · sponsor: **Vor Biopharma** · enrollment: 10 (actual)

## Conditions studied

- Leukemia, Myeloid, Acute

## Interventions

- **GENETIC:** VOR33

## Key facts

- **NCT ID:** NCT05309733
- **Lead sponsor:** Vor Biopharma
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2022-04-15
- **Primary completion:** 2025-05-28
- **Final completion:** 2025-05-28
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** Lack of Funding
- **Last updated:** 2025-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05309733

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05309733, "A Long-term Follow-up Study of Patients Who Received VOR33". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05309733. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*